JP2007106694A - Skin care agent for external use - Google Patents
Skin care agent for external use Download PDFInfo
- Publication number
- JP2007106694A JP2007106694A JP2005298834A JP2005298834A JP2007106694A JP 2007106694 A JP2007106694 A JP 2007106694A JP 2005298834 A JP2005298834 A JP 2005298834A JP 2005298834 A JP2005298834 A JP 2005298834A JP 2007106694 A JP2007106694 A JP 2007106694A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- skin
- oil
- microgel
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000178 monomer Substances 0.000 claims abstract description 45
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 27
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 26
- 229920001577 copolymer Polymers 0.000 claims abstract description 17
- 230000000379 polymerizing effect Effects 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 56
- 238000002360 preparation method Methods 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- -1 polyethylene Polymers 0.000 claims description 24
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- 239000003906 humectant Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 9
- 239000012046 mixed solvent Substances 0.000 claims description 9
- 239000004909 Moisturizer Substances 0.000 claims description 8
- 230000001333 moisturizer Effects 0.000 claims description 8
- 150000005846 sugar alcohols Polymers 0.000 claims description 5
- 238000010526 radical polymerization reaction Methods 0.000 claims description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 230000000699 topical effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 20
- 239000003795 chemical substances by application Substances 0.000 abstract description 14
- 238000004132 cross linking Methods 0.000 abstract description 2
- 230000014759 maintenance of location Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 66
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 47
- 239000002245 particle Substances 0.000 description 31
- 230000003020 moisturizing effect Effects 0.000 description 28
- 239000003921 oil Substances 0.000 description 27
- 235000019198 oils Nutrition 0.000 description 27
- 235000011187 glycerol Nutrition 0.000 description 24
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 23
- 235000019441 ethanol Nutrition 0.000 description 23
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- 238000004519 manufacturing process Methods 0.000 description 17
- 239000002537 cosmetic Substances 0.000 description 15
- 229960005070 ascorbic acid Drugs 0.000 description 14
- 238000011156 evaluation Methods 0.000 description 14
- 239000006185 dispersion Substances 0.000 description 13
- 238000006116 polymerization reaction Methods 0.000 description 13
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 12
- 239000004166 Lanolin Substances 0.000 description 12
- 235000019388 lanolin Nutrition 0.000 description 12
- 229940039717 lanolin Drugs 0.000 description 12
- 239000002211 L-ascorbic acid Substances 0.000 description 11
- 239000002253 acid Substances 0.000 description 11
- 235000000069 L-ascorbic acid Nutrition 0.000 description 10
- 239000003205 fragrance Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 239000008213 purified water Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 7
- 229940058015 1,3-butylene glycol Drugs 0.000 description 6
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 6
- 235000019437 butane-1,3-diol Nutrition 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 6
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000003925 fat Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
- 239000001509 sodium citrate Substances 0.000 description 6
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 6
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 6
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 6
- 229960000401 tranexamic acid Drugs 0.000 description 6
- 239000001993 wax Substances 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 5
- 229960005323 phenoxyethanol Drugs 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 4
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 4
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 229940042585 tocopherol acetate Drugs 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 3
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 3
- 235000019482 Palm oil Nutrition 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 235000015278 beef Nutrition 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 3
- 229960000735 docosanol Drugs 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002540 palm oil Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- UAFHRUBCOQPFFM-UHFFFAOYSA-N 1-(aminomethyl)cyclohexane-1-carboxylic acid Chemical compound NCC1(C(O)=O)CCCCC1 UAFHRUBCOQPFFM-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 235000021357 Behenic acid Nutrition 0.000 description 2
- 230000005653 Brownian motion process Effects 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 2
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 2
- XDBMXUKHMOFBPJ-ZAFYKAAXSA-N L-ascorbic acid 2-sulfate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OS(O)(=O)=O)=C1O XDBMXUKHMOFBPJ-ZAFYKAAXSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 2
- 240000000912 Macadamia tetraphylla Species 0.000 description 2
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 2
- 229940116226 behenic acid Drugs 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 238000005537 brownian motion Methods 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000002296 dynamic light scattering Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 2
- 229910000271 hectorite Inorganic materials 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229920001600 hydrophobic polymer Polymers 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- KCAMXZBMXVIIQN-UHFFFAOYSA-N octan-3-yl 2-methylprop-2-enoate Chemical compound CCCCCC(CC)OC(=O)C(C)=C KCAMXZBMXVIIQN-UHFFFAOYSA-N 0.000 description 2
- NZIDBRBFGPQCRY-UHFFFAOYSA-N octyl 2-methylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C(C)=C NZIDBRBFGPQCRY-UHFFFAOYSA-N 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 239000003505 polymerization initiator Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 230000001603 reducing effect Effects 0.000 description 2
- 239000010668 rosemary oil Substances 0.000 description 2
- 229940058206 rosemary oil Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 239000004711 α-olefin Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- AFQOCSDOKGNDNA-OBEHBXMUSA-N (2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one (Z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCC\C=C/CCCCCCCC(O)=O AFQOCSDOKGNDNA-OBEHBXMUSA-N 0.000 description 1
- VBURMNYQYXSQEL-VFAVKCLXSA-N (2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one (Z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O VBURMNYQYXSQEL-VFAVKCLXSA-N 0.000 description 1
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- IRVNEGRHQKGRGD-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O IRVNEGRHQKGRGD-WPXUHFOISA-N 0.000 description 1
- PBTPTBMYJPCXRQ-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O PBTPTBMYJPCXRQ-MGMRMFRLSA-N 0.000 description 1
- MHUOEHQATDLJFZ-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;octadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O MHUOEHQATDLJFZ-WPXUHFOISA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- UYZQWKKNVBJVOF-UHFFFAOYSA-N 1-decoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCC UYZQWKKNVBJVOF-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- SMBRHGJEDJVDOB-UHFFFAOYSA-N 2-methylpropanimidamide;dihydrochloride Chemical compound Cl.Cl.CC(C)C(N)=N SMBRHGJEDJVDOB-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- 125000004080 3-carboxypropanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C(O[H])=O 0.000 description 1
- NDHNBHXAALUAAJ-UHFFFAOYSA-N 4,5-dimorpholin-4-yl-1h-pyridazin-6-one Chemical compound C1COCCN1C=1C(O)=NN=CC=1N1CCOCC1 NDHNBHXAALUAAJ-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- JBRMEFWJFBHUKG-UHFFFAOYSA-N 4-[(diaminomethylideneamino)methyl]cyclohexane-1-carboxylic acid Chemical class NC(N)=NCC1CCC(C(O)=O)CC1 JBRMEFWJFBHUKG-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 1
- 244000266618 Atriplex confertifolia Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- UEQVLKWMHAYVLO-MGCOHNPYSA-N C1C[C@@H](CN)CC[C@@H]1C(=O)OC1=CC=C(O)C=C1C(O)=O Chemical compound C1C[C@@H](CN)CC[C@@H]1C(=O)OC1=CC=C(O)C=C1C(O)=O UEQVLKWMHAYVLO-MGCOHNPYSA-N 0.000 description 1
- AVWTXYWHGFHGQD-ZKCHVHJHSA-N CNC(=O)[C@H]1CC[C@H](CN)CC1 Chemical compound CNC(=O)[C@H]1CC[C@H](CN)CC1 AVWTXYWHGFHGQD-ZKCHVHJHSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- 102400000739 Corticotropin Human genes 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 102400000921 Gastrin Human genes 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 102000003792 Metallothionein Human genes 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- YQINWFJNFJEWHH-UCLHFMLVSA-N OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O YQINWFJNFJEWHH-UCLHFMLVSA-N 0.000 description 1
- NGUBAXUPKACQCL-UCLHFMLVSA-N OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O NGUBAXUPKACQCL-UCLHFMLVSA-N 0.000 description 1
- QDTPSCIFGGYXJD-IPKXSQMUSA-N OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O QDTPSCIFGGYXJD-IPKXSQMUSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 102400000050 Oxytocin Human genes 0.000 description 1
- 101800000989 Oxytocin Proteins 0.000 description 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 108010086019 Secretin Proteins 0.000 description 1
- 102100037505 Secretin Human genes 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 229920002253 Tannate Polymers 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229940050528 albumin Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229940009868 aluminum magnesium silicate Drugs 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 229940072065 ascorbic acid 2-sulfate Drugs 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- HRUVKSKSDDVGMC-JDYVBSGKSA-L disodium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;sulfate Chemical compound [Na+].[Na+].OS([O-])(=O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] HRUVKSKSDDVGMC-JDYVBSGKSA-L 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 229940072117 fennel extract Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- POOYFSLWYLDQMD-UHFFFAOYSA-N heptacalcium;zinc Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Zn+2] POOYFSLWYLDQMD-UHFFFAOYSA-N 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- MDNFYIAABKQDML-UHFFFAOYSA-N heptyl 2-methylprop-2-enoate Chemical compound CCCCCCCOC(=O)C(C)=C MDNFYIAABKQDML-UHFFFAOYSA-N 0.000 description 1
- SCFQUKBBGYTJNC-UHFFFAOYSA-N heptyl prop-2-enoate Chemical compound CCCCCCCOC(=O)C=C SCFQUKBBGYTJNC-UHFFFAOYSA-N 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-N hexanedioic acid Natural products OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- LNCPIMCVTKXXOY-UHFFFAOYSA-N hexyl 2-methylprop-2-enoate Chemical compound CCCCCCOC(=O)C(C)=C LNCPIMCVTKXXOY-UHFFFAOYSA-N 0.000 description 1
- LNMQRPPRQDGUDR-UHFFFAOYSA-N hexyl prop-2-enoate Chemical compound CCCCCCOC(=O)C=C LNMQRPPRQDGUDR-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 229940040461 lipase Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- QYZFTMMPKCOTAN-UHFFFAOYSA-N n-[2-(2-hydroxyethylamino)ethyl]-2-[[1-[2-(2-hydroxyethylamino)ethylamino]-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound OCCNCCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCCNCCO QYZFTMMPKCOTAN-UHFFFAOYSA-N 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- UVPGECJLXBGLDW-UHFFFAOYSA-N octadecan-7-ol Chemical compound CCCCCCCCCCCC(O)CCCCCC UVPGECJLXBGLDW-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- 229940065472 octyl acrylate Drugs 0.000 description 1
- ANISOHQJBAQUQP-UHFFFAOYSA-N octyl prop-2-enoate Chemical compound CCCCCCCCOC(=O)C=C ANISOHQJBAQUQP-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
- 229960001723 oxytocin Drugs 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000003921 particle size analysis Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- GYDSPAVLTMAXHT-UHFFFAOYSA-N pentyl 2-methylprop-2-enoate Chemical compound CCCCCOC(=O)C(C)=C GYDSPAVLTMAXHT-UHFFFAOYSA-N 0.000 description 1
- ULDDEWDFUNBUCM-UHFFFAOYSA-N pentyl prop-2-enoate Chemical compound CCCCCOC(=O)C=C ULDDEWDFUNBUCM-UHFFFAOYSA-N 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 229950011087 perflunafene Drugs 0.000 description 1
- UWEYRJFJVCLAGH-IJWZVTFUSA-N perfluorodecalin Chemical compound FC1(F)C(F)(F)C(F)(F)C(F)(F)[C@@]2(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)[C@@]21F UWEYRJFJVCLAGH-IJWZVTFUSA-N 0.000 description 1
- 239000010702 perfluoropolyether Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 239000005518 polymer electrolyte Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 238000009725 powder blending Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000001507 sample dispersion Methods 0.000 description 1
- 229960002101 secretin Drugs 0.000 description 1
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
- 229950000112 serrapeptase Drugs 0.000 description 1
- 108010038132 serratiopeptidase Proteins 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 229960005066 trisodium edetate Drugs 0.000 description 1
- XWNXEWLCHSLQOI-UHFFFAOYSA-K trisodium;triacetate Chemical compound [Na+].[Na+].[Na+].CC([O-])=O.CC([O-])=O.CC([O-])=O XWNXEWLCHSLQOI-UHFFFAOYSA-K 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 150000003697 vitamin B6 derivatives Chemical class 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は皮膚外用剤に関する。さらに詳しくは、保湿効果と肌荒れ改善効果に優れ、かつ使用感触に優れる皮膚外用剤に関する。 The present invention relates to an external preparation for skin. More specifically, the present invention relates to an external preparation for skin which is excellent in a moisturizing effect and a rough skin improving effect and excellent in touch feeling.
健康な皮膚を保つためには水分の保持が不可欠であり、保湿を目的とした皮膚外用剤が数多く開発されている。また、皮膚外用剤の使用感としては、なめらかさがありべたつき感のないものが求められている。
保湿剤に関する研究は盛んに行なわれている。そして、化粧水や乳液等に用いられている周知の保湿剤としてグリセリンが挙げられる(非特許文献1)。このグリセリンは保湿効果以外に肌荒れを改善する効果も有する(特許文献1)。
しかしながら、グリセリンは、保湿効果や肌荒れ改善効果を上げるためには配合量を増やさなければならない。その結果、系が不安定になったり、使用性が悪くなったり、また、皮膚に適用した場合、皮脂によりはじかれ、肌へのなじみが悪くなる等の解決すべき課題があった。
Moisture retention is indispensable for maintaining healthy skin, and many external preparations for the purpose of moisturizing have been developed. Further, as a feeling of use of the external preparation for skin, there is a demand for a smooth and non-sticky feeling.
There are many studies on moisturizers. And glycerin is mentioned as a well-known moisturizer used for a lotion, an emulsion, etc. (nonpatent literature 1). In addition to the moisturizing effect, this glycerin also has an effect of improving rough skin (Patent Document 1).
However, the amount of glycerin must be increased in order to increase the moisturizing effect and the effect of improving rough skin. As a result, there are problems to be solved such as the system becomes unstable, the usability deteriorates, and when it is applied to the skin, it is repelled by sebum and becomes unfit to the skin.
一方、グリセリン以外の保湿剤として、1,3−ブチレングリコール、プロピレングリコール、ポリエチレングリコール、ソルビトール、キシリトール等の多価アルコール類が知られている(特許文献2)。
しかし、これらの多価アルコール類は、グリセリンに比べるとべたつき感は少ないものの、保湿効果や肌荒れ改善効果は低い。また、グリセリン同様、皮膚に適用した場合、皮脂によりはじかれ、肌へのなじみが悪くなる等の解決すべき課題があった。
On the other hand, polyhydric alcohols such as 1,3-butylene glycol, propylene glycol, polyethylene glycol, sorbitol, and xylitol are known as humectants other than glycerin (Patent Document 2).
However, these polyhydric alcohols are less sticky than glycerin, but have a low moisturizing effect and rough skin improving effect. In addition, like glycerin, when applied to the skin, there are problems to be solved such as repelling by sebum and deterioration of the familiarity with the skin.
この保湿剤のべたつきを低減する目的として、粉末の配合が知られている(特許文献1)。
しかしながら、粉末を配合する場合、べたつき低減効果を出すためには大量に配合しなければならない。また、化粧水のように粘度の低い皮膚外用剤では、粉末が沈殿するため、振ってから使用しなければならず、面倒で手間がかかる。さらに、乳液においては、工程により粉末が溶けたり、製剤によっては粉末が膨潤するといった問題点があった。
For the purpose of reducing the stickiness of the moisturizer, powder blending is known (Patent Document 1).
However, when blending powder, a large amount must be blended in order to produce a stickiness reducing effect. In addition, in the case of a skin external preparation having a low viscosity such as a lotion, since the powder precipitates, it must be used after shaking, which is troublesome and troublesome. Furthermore, the emulsion has a problem that the powder dissolves depending on the process and the powder swells depending on the preparation.
前記目的を達成するために本発明者等が鋭意研究した結果、グリセリンなどの保湿剤とともに特定の共重合体からなるミクロゲルを併用すると、保湿剤の保湿効果、肌荒れ改善効果を損なうことなく、保湿剤に起因するべたつきが著しく改善されることを見出した。 As a result of intensive studies by the present inventors to achieve the above object, when a microgel comprising a specific copolymer is used in combination with a humectant such as glycerin, the moisturizer is maintained without damaging the moisturizing effect of the moisturizing agent and the effect of improving skin roughness. It was found that the stickiness caused by the agent was remarkably improved.
本発明の目的は、保湿及び肌荒れ改善効果とともに、使用感触に優れる皮膚外用剤を提供することにある。 The objective of this invention is providing the skin external preparation which is excellent in a feeling of use with a moisturizing and rough skin improvement effect.
すなわち、本発明は、下記式(1)のポリエチレンオキサイドマクロモノマーと下記式(2)の疎水性モノマーと下記式(3)の架橋性モノマーとを重合して得られる共重合体と、保湿剤とを含有することを特徴とする皮膚外用剤を提供するものである。
R1は炭素原子数1〜3のアルキルを表し、nは20〜200の数である。XはHまたはCH3を表す。
R2は炭素原子数1〜3のアルキルを表し、R3は炭素原子数1〜8のアルキルを表す。
R4とR5はそれぞれ独立に炭素原子数1〜3のアルキルを表し、mは0〜2の数である。
That is, the present invention relates to a copolymer obtained by polymerizing a polyethylene oxide macromonomer of the following formula (1), a hydrophobic monomer of the following formula (2) and a crosslinkable monomer of the following formula (3), and a humectant. An external preparation for skin characterized by containing the above.
R 1 represents alkyl having 1 to 3 carbon atoms, and n is a number from 20 to 200. X represents H or CH 3 .
R 2 represents alkyl having 1 to 3 carbon atoms, and R 3 represents alkyl having 1 to 8 carbon atoms.
R 4 and R 5 each independently represents alkyl having 1 to 3 carbon atoms, and m is a number from 0 to 2.
また、本発明は、下記(A)、(B)、(C)、(D)の条件下に、前記(1)〜(3)のモノマーを水−エタノール混合溶媒中にてラジカル重合して得られる共重合体からなるミクロゲルと、保湿剤とを配合したことを特徴とする皮膚外用剤を提供するものである。
(A)疎水性モノマーは炭素原子数1〜8のアルキルを有するメタクリル酸誘導体を一種もしくは二種以上を混合した組成であること
(B)ポリエチレンオキサイドマクロモノマーと疎水性モノマーの仕込み量が、ポリエチレンオキサイドマクロモノマー:疎水性モノマー=1:10〜1:250(モル比)であること
(C)架橋性モノマーの仕込み量が、疎水性モノマーの仕込み量に対して、0.1〜1.5質量%であること
(D)水−エタノール混合溶媒が、水:エタノール=90〜30:10〜70(20℃の容積比)であること
In the present invention, the monomers (1) to (3) are radically polymerized in a water-ethanol mixed solvent under the following conditions (A), (B), (C), and (D). The present invention provides a skin external preparation characterized by blending a microgel comprising a copolymer obtained and a humectant.
(A) The hydrophobic monomer has a composition in which one or more methacrylic acid derivatives having an alkyl having 1 to 8 carbon atoms are mixed. (B) The charged amount of the polyethylene oxide macromonomer and the hydrophobic monomer is polyethylene. Oxide macromonomer: hydrophobic monomer = 1: 10 to 1: 250 (molar ratio) (C) The charged amount of the crosslinkable monomer is 0.1 to 1.5 with respect to the charged amount of the hydrophobic monomer. (D) The water-ethanol mixed solvent is water: ethanol = 90-30: 10-70 (20 ° C. volume ratio).
さらに、本発明は、前記保湿剤が多価アルコールであることを特徴とする上記の皮膚外用剤を提供するものである。 Furthermore, this invention provides said skin external preparation characterized by the said moisturizer being a polyhydric alcohol.
(1)本発明の皮膚外用剤は高い保湿効果を有し、また肌荒れ改善効果を有する。
(2)本発明の皮膚外用剤は使用感に優れている。すなわち、なめらかであり、べたつきがない。特にべたつきが問題となるグリセリン配合の化粧料に有用である。
(3)本発明の皮膚外用剤は使用者に優れた保湿効果感を与える。
(1) The external preparation for skin of the present invention has a high moisturizing effect and also has an effect of improving skin roughness.
(2) The external preparation for skin of the present invention is excellent in use feeling. That is, it is smooth and has no stickiness. It is particularly useful for cosmetics containing glycerin where stickiness is a problem.
(3) The external preparation for skin of the present invention gives the user a superior moisturizing effect.
以下に本発明について詳述する。
「本発明に用いる共重合体について」
式(1)のポリエチレンオキサイドマクロモノマーは、例えばAldrich社から市販されている試薬、あるいは日本油脂から発売されているブレンマー(登録商標)を使用することが出来る。これら市販品の式(1)のポリエチレンオキサイド部分の分子量(即ちnの値)は幅広く、これを使用することができる。このポリエチレンオキサイド部分の分子量の好ましいサイズはn=20〜200のものである。例えば、日本油脂製ブレンマー(登録商標)PME1000あるいはブレンマー(登録商標)PME4000などが好適である。
The present invention is described in detail below.
"Copolymer used in the present invention"
As the polyethylene oxide macromonomer of the formula (1), for example, a reagent commercially available from Aldrich or Bremer (registered trademark) marketed by Nippon Oil & Fats can be used. The molecular weight (namely, the value of n) of these commercially available polyethylene oxide moieties of formula (1) is wide and can be used. The preferred molecular weight size of this polyethylene oxide moiety is n = 20-200. For example, Nippon Oil & Fats Blemmer (registered trademark) PME1000 or Blemmer (registered trademark) PME4000 is suitable.
式(2)の疎水性モノマーは、例えば、Aldrich社もしくは東京化成社から市販されている試薬を使用することができる。式(2)のR3のアルキル鎖は炭素原子数1〜8のアルキルである。式(2)は、アクリル酸メチル、アクリル酸エチル、アクリル酸プロピル、アクリル酸ブチル、アクリル酸ペンチル、アクリル酸ヘキシル、アクリル酸へプチル、アクリル酸オクチル、メタクリル酸メチル、メタクリル酸エチル、メタクリル酸プロピル、メタクリル酸ブチル、メタクリル酸ペンチル、メタクリル酸ヘキシル、メタクリル酸へプチル、メタクリル酸オクチルなどである。特に、メチルメタクリレート、ブチルメタクリレート、オクチルメタクリレートが好適である。これらの疎水性モノマーは汎用原料であり、一般工業原料としても容易に入手することができる。 As the hydrophobic monomer of the formula (2), for example, a reagent commercially available from Aldrich or Tokyo Kasei can be used. The alkyl chain of R 3 in formula (2) is alkyl having 1 to 8 carbon atoms. Formula (2) is methyl acrylate, ethyl acrylate, propyl acrylate, butyl acrylate, pentyl acrylate, hexyl acrylate, heptyl acrylate, octyl acrylate, methyl methacrylate, ethyl methacrylate, propyl methacrylate. Butyl methacrylate, pentyl methacrylate, hexyl methacrylate, heptyl methacrylate, octyl methacrylate and the like. In particular, methyl methacrylate, butyl methacrylate, and octyl methacrylate are suitable. These hydrophobic monomers are general-purpose raw materials and can be easily obtained as general industrial raw materials.
式(3)の架橋性モノマーは、市販の試薬あるいは工業用原料として入手が可能である。この架橋性モノマーは疎水的であることが好ましい。式(3)のmの値は好ましくは1〜3である。具体的にはAldrich社から発売されているエチレングリコールジメタクリレート、日本油脂製ブレンマー(登録商標)PDE−50などが好適である。 The crosslinkable monomer of the formula (3) can be obtained as a commercially available reagent or an industrial raw material. This crosslinkable monomer is preferably hydrophobic. The value of m in the formula (3) is preferably 1 to 3. Specifically, ethylene glycol dimethacrylate sold by Aldrich, Bremer (registered trademark) PDE-50 manufactured by NOF Corporation is suitable.
本発明に用いる共重合体は、任意の重合法により上記モノマーを共重合体させたものであるが、特に下記(A)、(B)、(C)の条件下に、前記(1)〜(3)のモノマーを水−エタノール混合溶媒中にてラジカル重合して得られる共重合体(ミクロゲル)であることが好ましい。
(A)ポリエチレンオキサイドマクロモノマーと疎水性モノマーの仕込み量が、ポリエチレンオキサイドマクロモノマー:疎水性モノマー=1:10〜1:250(モル比)であること
(B)架橋性モノマーの仕込み量が、疎水性モノマーの仕込み量に対して、0.1〜1.5質量%であること
(C)水−エタノール混合溶媒が、水:エタノール=90〜30:10〜70(20℃の容積比)であること
The copolymer used in the present invention is obtained by copolymerizing the above monomer by an arbitrary polymerization method, and in particular, under the conditions (A), (B) and (C) below, It is preferable that it is a copolymer (microgel) obtained by radical polymerization of the monomer (3) in a water-ethanol mixed solvent.
(A) The charged amount of polyethylene oxide macromonomer and hydrophobic monomer is polyethylene oxide macromonomer: hydrophobic monomer = 1: 10 to 1: 250 (molar ratio) (B) The charged amount of crosslinkable monomer is It is 0.1-1.5 mass% with respect to the preparation amount of a hydrophobic monomer. (C) Water-ethanol mixed solvent is water: ethanol = 90-30: 10-70 (20 degreeC volume ratio). Be
(A)のポリエチレンオキサイドマクロモノマーと疎水性モノマーの仕込み量は、ポリエチレンオキサイドマクロモノマー:疎水性モノマー=1:10〜1:250(モル比)の範囲でコロナ−コア型ミクロゲルが重合可能である。エチレンオキサイドマクロモノマーの仕込み量が、モル比で疎水性モノマーの10分の1を下回ると重合されるポリマーは水溶性になりコロナ−コア型ポリマーミクロゲルは形成しない。またポリエチレンオキサイドマクロモノマーのモル量に対して疎水性モノマーが250倍以上になるとポリエチレンオキサイドマクロモノマーによる分散安定化が不完全になり不溶性の疎水性モノマーによる疎水性ポリマーが凝集、沈殿する。ポリエチレンオキサイドマクロモノマーと疎水性モノマーの仕込み比は、好ましくは1:10〜1:200の範囲である。さらに好ましくは1:25から1:100の範囲である。 The charged amount of the polyethylene oxide macromonomer and the hydrophobic monomer (A) is within the range of polyethylene oxide macromonomer: hydrophobic monomer = 1: 10 to 1: 250 (molar ratio), and the corona-core type microgel can be polymerized. . When the charged amount of the ethylene oxide macromonomer is less than 1/10 of the hydrophobic monomer by molar ratio, the polymer to be polymerized becomes water-soluble and no corona-core type polymer microgel is formed. Further, when the hydrophobic monomer becomes 250 times or more with respect to the molar amount of the polyethylene oxide macromonomer, the dispersion stabilization by the polyethylene oxide macromonomer becomes incomplete, and the hydrophobic polymer by the insoluble hydrophobic monomer aggregates and precipitates. The charging ratio of the polyethylene oxide macromonomer and the hydrophobic monomer is preferably in the range of 1:10 to 1: 200. More preferably, it is in the range of 1:25 to 1: 100.
(B)の架橋性モノマーを共重合することでコア部分の疎水性ポリマーが架橋されたミクロゲルを重合することが出来る。架橋性モノマーの仕込み量が疎水性モノマーの仕込み量の0.1重量%未満であると、架橋密度が低く、このミクロゲルは膨潤時に崩壊してしまう。また1.5重量%を上回ると、ミクロゲル粒子同士の凝集が生じ、粒度分布の狭い好適なミクロゲル粒子を重合することは出来ない。好ましい架橋性モノマーの仕込み量は,0.2〜1.0、さらに好ましくは0.2〜0.8、最も好ましくは0.2〜0.5重量%である。 By copolymerizing the crosslinkable monomer (B), a microgel in which the hydrophobic polymer in the core portion is crosslinked can be polymerized. If the charge amount of the crosslinkable monomer is less than 0.1% by weight of the charge amount of the hydrophobic monomer, the crosslink density is low, and the microgel collapses when swollen. On the other hand, when the content exceeds 1.5% by weight, the microgel particles are aggregated and suitable microgel particles having a narrow particle size distribution cannot be polymerized. The amount of the crosslinkable monomer charged is preferably 0.2 to 1.0, more preferably 0.2 to 0.8, and most preferably 0.2 to 0.5% by weight.
(C)の重合溶媒である水/エタノールの混合比は、水−エタノール混合溶媒が、水:エタノール=90〜30:10〜70(20℃の容積比)である。重合溶媒は疎水性モノマーを均一溶解するためにエタノールを加えることが必要である。エタノールの混合比は10〜60容量比である。エタノールの混合比が10容量比より低い場合は疎水性モノマーを可溶化することが困難になり、重合されるミクロゲル粒子の粒度分布が広くなってしまう。またエタノールの混合比が60容量比を上回ると、重合されるポリマーは重合溶媒に溶解してしまい、ミクロゲル粒子は得られない。好ましい水/エタノールの混合比は、水−エタノール混合溶媒が、水:エタノール=90〜60:10〜40(20℃の容積比)である。さらに好ましくは水:エタノール=80〜70:20〜30(20℃の容積比)である。 The mixing ratio of water / ethanol which is the polymerization solvent of (C) is such that the water-ethanol mixed solvent is water: ethanol = 90-30: 10-70 (volume ratio at 20 ° C.). The polymerization solvent needs to add ethanol in order to uniformly dissolve the hydrophobic monomer. The mixing ratio of ethanol is 10-60 volume ratio. When the mixing ratio of ethanol is lower than 10 volume ratio, it becomes difficult to solubilize the hydrophobic monomer, and the particle size distribution of the microgel particles to be polymerized becomes wide. When the mixing ratio of ethanol exceeds 60 volume ratio, the polymer to be polymerized is dissolved in the polymerization solvent, and microgel particles cannot be obtained. A preferable water / ethanol mixing ratio is such that the water-ethanol mixed solvent is water: ethanol = 90 to 60:10 to 40 (volume ratio of 20 ° C.). More preferably, it is water: ethanol = 80-70: 20-30 (20 degreeC volume ratio).
この重合系に用いられる重合開始剤は通常の水溶性熱ラジカル重合に用いられる市販の重合開始剤を用いることが出来る。
この重合系では特に攪拌条件を厳密にコントロールすることなく重合を行っても重合されるミクロゲル粒子の粒度分布は非常に狭いものを得ることが出来る。
As the polymerization initiator used in this polymerization system, a commercially available polymerization initiator used for usual water-soluble thermal radical polymerization can be used.
In this polymerization system, it is possible to obtain a very narrow particle size distribution of the polymerized microgel particles even when polymerization is performed without strictly controlling the stirring conditions.
上述の製造方法により、粒子径が50〜300nmでありその分散度が0.01未満の単分散性粒子からなるミクロゲルが得られる。なお、このミクロゲルは有機溶媒に膨潤するという特質を有する。 By the above production method, a microgel composed of monodisperse particles having a particle diameter of 50 to 300 nm and a dispersity of less than 0.01 is obtained. In addition, this microgel has the characteristic that it swells in an organic solvent.
なお、一般的に乳化粒子あるいはポリマーエマルションなどの所謂コロイド粒子の粒子径は動的光散乱法あるいは光子相関法と呼ばれる方法で測定が可能である。この測定法は、十分に希薄な濃度に調製したサンプル分散液にレーザー光を照射し、サンプル粒子から散乱される散乱光強度を測定することで、サンプル粒子の並進拡散係数(平均値)を測定する方法である。サンプル粒子は分散液中でブラウン運動で常に動いている。このブラウン運動による粒子の移動速度、即ち並進拡散係数(平均値)を散乱光強度の時間変化の結果から、解析することが出来る。こうして得られた並進拡散係数(平均値)の値からストークス−アインシュタイン式(数1)に従ってサンプル粒子の流体力学的サイズを計算することが出来る。
この測定は市販の測定装置で簡便に測定可能である。たとえば大塚電子製 DLS7000、マーベルン製 ゼータサイザー4700、ブルックヘーブン製 ゼータプラスなどで測定が可能である。
上述の市販の測定装置にはデータ解析ソフトが搭載されており、測定データを自動的に解析することが出来る。この解析ソフトを用いることで平均粒子径、分散度の値を得ることが出来る。ここで分散度とは粒子径の平均値からのばらつきを示す値であり、キュムラント解析における二次キュムラントの値、即ち、分散値を規格化した値である。一般的にこの分散度が0.01以下であればそのサンプルの粒子径分布はほぼ単分散とみなすことが出来る。
In general, the particle diameter of so-called colloidal particles such as emulsified particles or polymer emulsions can be measured by a method called dynamic light scattering method or photon correlation method. This measurement method measures the translational diffusion coefficient (average value) of sample particles by irradiating a sample dispersion prepared to a sufficiently dilute concentration with laser light and measuring the intensity of scattered light scattered from the sample particles. It is a method to do. Sample particles are constantly moving in the dispersion with Brownian motion. The moving speed of the particles by the Brownian motion, that is, the translational diffusion coefficient (average value) can be analyzed from the result of the temporal change in the scattered light intensity. The hydrodynamic size of the sample particles can be calculated from the translation diffusion coefficient (average value) thus obtained according to the Stokes-Einstein equation (Equation 1).
This measurement can be easily performed with a commercially available measuring apparatus. For example, measurement is possible with Otsuka Electronics DLS7000, Marveln Zetasizer 4700, Brookhaven Zeta Plus.
The above-mentioned commercially available measuring apparatus is equipped with data analysis software, and can automatically analyze measurement data. By using this analysis software, values of average particle diameter and degree of dispersion can be obtained. Here, the degree of dispersion is a value indicating a variation from the average value of the particle diameter, and is a value of the secondary cumulant in the cumulant analysis, that is, a value obtained by normalizing the dispersion value. In general, if the degree of dispersion is 0.01 or less, the particle size distribution of the sample can be regarded as almost monodisperse.
なお、従来の合成高分子によるミクロゲルは、いずれも高分子電解質、例えばポリアクリル酸を応用したものであり、その水への分散性に耐酸性や耐塩性がないものであった。しかしながら、医薬品や化粧品の配合成分として応用を考える際、生理的条件化での適応においては耐酸性や耐塩性は非常に重要な性能である。本発明の上記ミクロゲルは非イオン性高分子であるポリエチレンオキサイド鎖で安定化されたミクロゲルであり、その水中での分散安定性は耐酸性や耐塩性が期待できる。
また、水溶性高分子構造を含むマクロモノマーを応用したマクロモノマー法による高分子微粒子重合法は知られているが、この方法を応用して、コア部分を架橋性モノマーにより架橋させてミクロゲルを製造する方法は知られていない。
本発明で使用するミクロゲルは、親水性マクロモノマーと疎水性モノマーとが溶媒中にて図1に示すように秩序化が起り、粒子径がほぼ一定で、かつコア部分が架橋されたコロナ−コア型高分子ミクロゲルが生成すると考えられる。
In addition, all the conventional microgels made of synthetic polymers are those using a polymer electrolyte such as polyacrylic acid, and have no acid resistance or salt resistance in water dispersibility. However, when considering application as a compounding ingredient of pharmaceuticals and cosmetics, acid resistance and salt resistance are very important performances in adaptation under physiological conditions. The microgel of the present invention is a microgel stabilized with a polyethylene oxide chain, which is a nonionic polymer, and its dispersion stability in water can be expected to have acid resistance and salt resistance.
Also known is a polymer microparticle polymerization method using a macromonomer method that applies a macromonomer containing a water-soluble polymer structure, but this method is applied to produce a microgel by crosslinking the core with a crosslinkable monomer. There is no known way to do it.
The microgel used in the present invention is a corona-core in which hydrophilic macromonomer and hydrophobic monomer are ordered in a solvent as shown in FIG. 1, the particle diameter is substantially constant, and the core portion is crosslinked. Type polymer microgel is considered to be formed.
以上が本発明に用いる共重合体の説明である。本発明の皮膚外用剤は、この共重合体を、水(又は水溶性の化粧料成分が溶解した水相)に常法により混合分散させることによって製造される。すなわち、本発明の皮膚外用剤は極めて簡単な製造プロセスによって生産可能という優れた商業的価値を有する化粧料である。 The above is the description of the copolymer used in the present invention. The external preparation for skin of the present invention is produced by mixing and dispersing this copolymer in water (or an aqueous phase in which water-soluble cosmetic ingredients are dissolved) by a conventional method. That is, the external preparation for skin of the present invention is a cosmetic having an excellent commercial value that can be produced by a very simple manufacturing process.
本発明で使用されるミクロゲルはイオン交換水中へ分散させたときの粒径が250nm以下のものを使用するのが望ましい。250nmを超える粒径のものでは高温条件下での長期保存において安定性の観点から化粧料として好ましくない場合や、使用感が好まれなくなる場合がある。 The microgel used in the present invention preferably has a particle size of 250 nm or less when dispersed in ion-exchanged water. When the particle diameter exceeds 250 nm, it may not be preferable as a cosmetic from the viewpoint of stability during long-term storage under high temperature conditions, or the feeling of use may not be preferred.
本発明で使用されるミクロゲルは、皮膚外用剤の全量に対して通常0.001質量%以上の範囲で配合するのが望ましい。ミクロゲルの配合量が0.001質量%未満では使用感の改善効果が得られにくい。 The microgel used in the present invention is preferably blended in the range of usually 0.001% by mass or more based on the total amount of the external preparation for skin. When the blending amount of the microgel is less than 0.001% by mass, it is difficult to obtain an effect of improving the feeling of use.
本発明に用いる上記ミクロゲルは、水に僅か0.001質量%配合するだけで保湿剤の特徴的なべたつきを軽減することが確認でき、配合により使用性改善剤として機能するものである。従来の技術では保湿剤高配合による保湿効果を維持しつつ、塗布時および乾燥後の肌のべたつきが抑制することが難しいものであった。 The microgel used in the present invention can be confirmed to reduce the characteristic stickiness of the moisturizing agent only by adding 0.001% by mass in water, and functions as a usability improving agent by mixing. In the prior art, it has been difficult to suppress the stickiness of the skin at the time of application and after drying while maintaining the moisturizing effect due to the high formulation of the moisturizing agent.
本発明の皮膚外用剤は、上記ミクロゲルおよび保湿剤を同時に配合した化粧料が好ましい。なぜなら、保湿剤を配合した化粧料は、従来の技術では保湿効果と使用感のバランスの調整が非常に困難であり、使用感を重視する化粧料の製造が困難だからである。
保湿剤の配合量は、皮膚外用剤全量に対して0.1質量%以上40質量%未満が好ましい。
The external preparation for skin of the present invention is preferably a cosmetic containing the microgel and a humectant at the same time. This is because a cosmetic containing a moisturizing agent is very difficult to adjust the balance between the moisturizing effect and the feeling of use in the prior art, and it is difficult to produce a cosmetic that emphasizes the feeling of use.
The amount of the moisturizer is preferably 0.1% by mass or more and less than 40% by mass with respect to the total amount of the external preparation for skin.
本発明に用いられる保湿剤は多価アルコールが好ましい。特にグリセリンが好ましく、またグリセリン以外の保湿剤として、ポリエチレングリコール、1,3−ブチレングリコール、エリスリトール、ジプロピレングリコール、ベタイン、ソルビトール、キシリトール、マルチトール、ムコ多糖、ヒアルロン酸、コンドロイチン硫酸、キチン、キトサン等などが挙げられる。 The humectant used in the present invention is preferably a polyhydric alcohol. In particular, glycerin is preferable, and as a humectant other than glycerin, polyethylene glycol, 1,3-butylene glycol, erythritol, dipropylene glycol, betaine, sorbitol, xylitol, maltitol, mucopolysaccharide, hyaluronic acid, chondroitin sulfate, chitin, chitosan Etc.
本発明の皮膚外用剤は、スキンケア製品、メーキャップ製品、ヘアケア製品に使用することができる。特にスキンケア製品として使用されることが好ましく、化粧水・乳液・美容液・クリーム・含浸マスク・ボディーローション・洗顔料など形態にこだわらない。 The skin external preparation of the present invention can be used for skin care products, makeup products, and hair care products. In particular, it is preferably used as a skin care product, and does not stick to forms such as lotion, milky lotion, serum, cream, impregnation mask, body lotion, face wash.
本発明の皮膚外用剤には、さらに化粧料、医薬品等に通常使用される薬効剤、保湿成分、抗炎症剤、殺菌剤、防腐剤、紫外線吸収剤、酸化防止剤、有機及び無機粉体、香料、色素などを必要に応じて配合することができる。 The skin external preparation of the present invention further includes a medicinal agent, a moisturizing ingredient, an anti-inflammatory agent, a bactericidal agent, an antiseptic, an ultraviolet absorber, an antioxidant, an organic and inorganic powder, which are usually used in cosmetics, pharmaceuticals, etc. A fragrance | flavor, a pigment | dye, etc. can be mix | blended as needed.
本発明の皮膚外用剤は、油分と、この油分に溶解する油溶性薬剤及び/又は香料を配合した化粧料においても、保湿効果および使用感に優れた皮膚外用剤を提供できる。この場合も、上述したように、保湿剤配合量は、皮膚外用剤全量に対して、0.01〜40質量%未満が好ましい。 The skin external preparation of the present invention can provide a skin external preparation excellent in moisturizing effect and usability even in a cosmetic comprising an oil and an oil-soluble drug and / or fragrance that dissolves in the oil. Also in this case, as described above, the humectant content is preferably 0.01 to less than 40% by mass with respect to the total amount of the external preparation for skin.
皮膚外用剤に配合する油状成分は、液状油分、固型油分、半固型油分又は水に難溶性の物質のいずれでもよい。例えば、アボカド油、ツバキ油、タートル油、マカデミアナッツ油、トウモロコシ油、ミンク油、オリーブ油、ナタネ油、卵黄油、ゴマ油、パーシック油、小麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワー油、綿実油、月見草油、エノ油、大豆油、落花生油、茶実油、カヤ油、コメヌカ油、シナギリ油、日本キリ油、ホホバ油、胚芽油、トリグリセリン、トリオクタン酸グリセリン、トリイソパルミチン酸グリセリン等の液体油脂、カカオ脂、ヤシ油、馬脂、硬化ヤシ油、パーム油、牛脂、羊脂、硬化牛脂、パーム核油、豚脂、牛骨脂、モクロウ核油、硬化油、牛脚脂、モクロウ、硬化ヒマシ油等の固型油脂、ミツロウ、カンデリラロウ、綿ロウ、カルナバロウ、ベイベリーロウ、イボタロウ、鯨ロウ、モンタンロウ、ヌカロウ、ラノリン、カボックロウ、酢酸ラノリン、液状ラノリン、サトウキビロウ、ラノリン脂肪酸イソプロピル、ラウリン酸ヘキシル、還元ラノリン、ジョジョバロウ、硬質ラノリン、セラックロウ、POEラノリンアルコールエーテル、POEラノリンアルコールアセテート、ラノリン脂肪酸ポリエチレングリコール、POE水素添加ラノリンアルコールエーテル等のロウ類、流動パラフィン、オゾケライト、スクワレン、プリスタン、パラフィン、セレシン、スクワラン、ワセリン、マイクロクリスタリンワックス等の炭化水素、ミリスチン酸イソプロピル、オクタン酸セチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、ステアリン酸ブチル、ラウリン酸ヘキシル、ミリスチン酸ミリスチル、オレイン酸デシル、ジメチルオクタン酸ヘキシルデシル、乳酸セチル、乳酸ミリスチル、酢酸ラノリン、ステアリン酸イソセチル、イソステアレン酸イソセチル、12−ヒドロキシステアリル酸コレステリル、ジ−2−エチルヘキシル酸エチレングリコール、ジペンタエリスリトール脂肪酸エステル、モノイソステアリン酸N−アルキルグリコール、ジカプリン酸ネオペンチルグリコール、リンゴ酸ジイソステアリル、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキシル酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキシル酸ペンタエリスリトール、トリ−2−エチルヘキシル酸グリセリン、トリイソステアリン酸トリメチロールプロパン、セチル−2−エチルヘキサノエート、2−エチルヘキシルパルミテート、トリミリスチン酸グリセリン、トリ−2−ヘプチルウンデカン酸グリセライド、ヒマシ油脂肪酸メチルエステル、オレイン酸オイル、セトステアリルアルコール、アセトグリセライド、パルミチン酸−2−ヘプチルウンデシル、アジピン酸ジイソプロピル、N−ラウロイル−L−グルタミン酸−2−オクチルドデシルエステル、アジピン酸ジ−2−ヘプチルウンデシル、エチルラウレート、セパチン酸ジ−2−エチルヘキシル、ミリスチン酸−2−ヘキシルデシル、パルミチン酸−2−ヘキシルデシル、アジピン酸−2−ヘキシルデシル、セバチル酸ジイソプロピル、コハク酸−2−エチルヘキシル、酢酸エチル、酢酸ブチル、酢酸アミル、クエン酸トリエチル等の合成エステル、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸(ベヘニル)酸、オレイン酸、12−ヒドロキシステアリン酸、ウンデシレン酸、トール酸、ラノリン脂肪酸、イソステアリン酸、リノール酸、リノレイン酸、エイコサペンタエン酸等の高級脂肪酸、ラウリンアルコール、セチルアルコール、ステアリルアルコール、ベヘニルアルコール、ミリスチルアルコール、オレイルアルコール、セトステアリルアルコール、モノステアリルグリセレンエーテル(バチルアルコール)、2−デシルテトラデシノール、ラノリンアルコール、コレステロール、ヘキシルドデカノール、イソステアリルアルコール、オクチルドデカノール等の直鎖、分岐高級アルコール、ジメチルポリシロキサン、メチルフェニルポリシロキサン等のシリコーン油、パーフルオロデカリン、パーフルオロヘキサン、トリパーフルオロ−n−ブチルアミン等のパーフルオロカーボンないしパーフルオロポリエーテル、ビタミンA及びその誘導体、ビタミンD及びその誘導体、ビタミンE及びその誘導体、ビタミンK及びその誘導体等のビタミン類、ステロール類、天然及び合成の香料等が挙げられ、このうち融点が常温以下を液状油分、融点が常温以上を固型、半固型油分と区別される。これらのなかで、特に液状極性油分を配合することが最も好ましい。 The oily component to be blended in the external preparation for skin may be any of a liquid oil, a solid oil, a semi-solid oil, or a substance hardly soluble in water. For example, avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, flaxseed oil, safflower oil, Cottonseed oil, evening primrose oil, eno oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, cinnagiri oil, Japanese kiri oil, jojoba oil, germ oil, triglycerin, trioctanoic acid glycerin, triisopalmitic acid glycerin, etc. Liquid oil, cacao oil, coconut oil, horse fat, hydrogenated palm oil, palm oil, beef tallow, sheep fat, hydrogenated beef tallow, palm kernel oil, pork fat, beef bone fat, owl kernel oil, hydrogenated oil, cow leg fat, Solid oils and fats such as mole, hardened castor oil, beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, ibota wax, whale wax, montan wax, nukarou, Norin, cabbage wax, lanolin acetate, liquid lanolin, sugar cane wax, lanolin fatty acid isopropyl, hexyl laurate, reduced lanolin, jojoballow, hard lanolin, shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate, lanolin fatty acid polyethylene glycol, POE hydrogenated Waxes such as lanolin alcohol ether, liquid paraffin, ozokerite, squalene, pristane, paraffin, ceresin, squalane, petrolatum, microcrystalline wax, hydrocarbons such as isopropyl myristate, octyl octoate, octyldodecyl myristate, isopropyl palmitate, Butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, dimethylo Hexyldecyl tannate, cetyl lactate, myristyl lactate, lanolin acetate, isocetyl stearate, isocetyl isostearate, cholesteryl 12-hydroxystearylate, ethylene glycol di-2-ethylhexylate, dipentaerythritol fatty acid ester, N-alkyl monoisostearate Glycol, neopentyl glycol dicaprate, diisostearyl malate, glycerin di-2-heptylundecanoate, trimethylolpropane tri-2-ethylhexylate, trimethylolpropane triisostearate, pentaerythritol tetra-2-ethylhexylate, tri Glycerin-2-ethylhexylate, trimethylolpropane triisostearate, cetyl-2-ethylhexanoate, 2-ethylhexylpa Lumitate, glyceryl trimyristate, glyceride tri-2-heptylundecanoate, castor oil fatty acid methyl ester, oleic acid oil, cetostearyl alcohol, acetoglyceride, 2-heptylundecyl palmitate, diisopropyl adipate, N-lauroyl- L-glutamic acid-2-octyldodecyl ester, di-2-heptylundecyl adipate, ethyl laurate, di-2-ethylhexyl sepatate, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, adipic acid 2-hexyldecyl, diisopropyl sebacate, 2-ethylhexyl succinate, ethyl acetate, butyl acetate, amyl acetate, triethyl citrate, synthetic esters, lauric acid, myristic acid, palmitic acid, Higher fatty acids such as formic acid, behenic acid (behenyl) acid, oleic acid, 12-hydroxystearic acid, undecylenic acid, tolic acid, lanolin fatty acid, isostearic acid, linoleic acid, linolenic acid, eicosapentaenoic acid, lauric alcohol, cetyl alcohol , Stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, cetostearyl alcohol, monostearyl glycerene ether (batyl alcohol), 2-decyltetradecinol, lanolin alcohol, cholesterol, hexyldodecanol, isostearyl alcohol, octyldodecanol, etc. Linear, branched higher alcohols, silicone oils such as dimethylpolysiloxane and methylphenylpolysiloxane, perfluorodecalin, perfluoro Perfluorocarbons or perfluoropolyethers such as hexane, triperfluoro-n-butylamine, vitamin A and its derivatives, vitamin D and its derivatives, vitamin E and its derivatives, vitamins such as vitamin K and its derivatives, sterols, Natural and synthetic fragrances and the like can be mentioned. Among them, a melting point of a normal temperature or lower is distinguished from a liquid oil, and a melting point of a normal temperature or higher is distinguished from a solid or semisolid oil. Among these, it is most preferable to add a liquid polar oil.
薬剤成分は、油溶性、水溶性、両親媒性のいずれも適用し得る。具体的には、例えば、美白剤、抗炎症剤、抗菌剤、ホルモン剤、ビタミン類、各種アミノ酸およびその誘導体や酵素、抗酸化剤、育毛剤などの薬剤が挙げられる。
美白剤としては、アルブチン等のハイドロキノン誘導体、コウジ酸、L−アスコルビン酸(ビタミンC)およびその誘導体、パントテニールエチルエーテル、トラネキサム酸およびその誘導体、プラセンタエキスや植物抽出物(例えばカミツレエキス等)等の各種抽出物などが例示される。
L−アスコルビン酸誘導体としては、例えばL−アスコルビン酸モノステアレート、L−アスコルビン酸モノパルミテート、L−アスコルビン酸モノオレート等のL−アスコルビン酸モノアルキルエステル類、L−アスコルビン酸モノリン酸エステル、L−アスコルビン酸−2−硫酸エステルなどのL−アスコルビン酸モノエステル類;L−アスコルビン酸ジステアレート、L−アスコルビン酸ジパルミテート、L−アスコルビン酸ジオレートなどのL−アスコルビン酸ジアルキルエステル類;L−アスコルビン酸ジリン酸エステルなどのL−アスコルビン酸ジエステル類;L−アスコルビン酸トリステアレート、L−アスコルビン酸トリパルミテート、L−アスコルビン酸トリオレートなどのL−アスコルビン酸トリアルキルエステル類;L−アスコルビン酸トリリン酸エステルなどのアスコルビン酸トリエステル類;L−アスコルビン酸2−グルコシドなどのL−アスコルビン酸グルコシド類などが挙げられる。L−アスコルビン酸およびその誘導体としては、L−アスコルビン酸、L−アスコルビン酸リン酸エステル、L−アスコルビン酸−2−硫酸エステル、L−アスコルビン酸2−グルコシドまたはそれらの塩が挙げられる。
トラネキサム酸誘導体としては、トラネキサム酸の二量体(例えば、塩酸トランス−4−(トランス−アミノメチルシクロヘキサンカルボニル)アミノメチルシクロヘキサンカルボン酸、等)、トラネキサム酸とハイドロキノンのエステル体(例えば、トランス−4−アミノメチルシクロヘキサンカルボン酸4’−ヒドロキシフェニルエステル、等)、トラネキサム酸とゲンチシン酸のエステル体(例えば、2−(トランス−4−アミノメチルシクロヘキシルカルボニルオキシ)−5−ヒドロキシ安息香酸およびその塩、等)、トラネキサム酸のアミド体(例えば、トランス−4−アミノメチルシクロヘキサンカルボン酸メチルアミドおよびその塩、トランス−4−(P−メトキシベンゾイル)アミノメチルシクロヘキサンカルボン酸およびその塩、トランス−4−グアニジノメチルシクロヘキサンカルボン酸およびその塩、等)などが挙げられる。
抗炎症剤としては、例えばグリチルリチン、グリチルリチン酸塩(例えばグリチルリチン酸ジカリウム、グリチルリチン酸アンモニウム、等)、アラントインなどが挙げられる。
抗菌剤としては、例えばレゾルシン、イオウ、サリチル酸などが挙げられる。
ホルモン剤としては、例えばオキシトシン、コルチコトロピン、バソプレッシン、セクレチン、ガストリン、カルシトニン、ヒノキチオール、エチニルエストラジオールなどが挙げられる。
ビタミン類としては、例えばビタミンAおよびその誘導体(例えば、レチノール、ビタミンAパルミテート、等)、ビタミンB6、ビタミンB6塩酸塩等のビタミンB6誘導体、ニコチン酸、ニコチン酸アミド等のニコチン酸誘導体、ビタミンEおよびその誘導体、β−カロチンなどが挙げられる。
各種アミノ酸およびその誘導体や酵素としては、例えばL−グルタミン酸やウロカニン酸、トリプシン、塩化リゾチーム、キモトリプシン、セミアルカリプロテナーゼ、セラペプターゼ、リパーゼ、ヒアルロニダーゼなどが挙げられる。
抗酸化剤としては、例えばチオタウリン、グルタチオン、カテキン、アルブミン、フェリチン、メタロチオネインなどが挙げられる。
育毛剤としては、例えばβ−グリチルレチン酸、パントテニルエチルエーテル、ミノキシジルなどが挙げられる。
また、カンファー、メントール等の清涼剤も用いられ得る。
The drug component may be any of oil-soluble, water-soluble, and amphiphilic. Specific examples include whitening agents, anti-inflammatory agents, antibacterial agents, hormone agents, vitamins, various amino acids and their derivatives, enzymes, antioxidants, hair restorers and the like.
Examples of whitening agents include hydroquinone derivatives such as arbutin, kojic acid, L-ascorbic acid (vitamin C) and derivatives thereof, pantotenyl ethyl ether, tranexamic acid and derivatives thereof, placenta extract and plant extract (eg chamomile extract), etc. Examples of these extracts are exemplified.
Examples of L-ascorbic acid derivatives include L-ascorbic acid monostearate, L-ascorbic acid monopalmitate, L-ascorbic acid monoalkyl esters such as L-ascorbic acid monooleate, L-ascorbic acid monophosphate, L L-ascorbic acid monoesters such as ascorbic acid-2-sulfate; L-ascorbic acid dialkyl esters such as L-ascorbic acid distearate, L-ascorbic acid dipalmitate, L-ascorbic acid dioleate; L-ascorbic acid dilin L-ascorbic acid diesters such as acid esters; L-ascorbic acid trialkyl esters such as L-ascorbic acid tristearate, L-ascorbic acid tripalmitate, L-ascorbic acid trioleate; - ascorbic acid triesters such as ascorbic acid triphosphate ester; and L- ascorbic acid glucosides such as L- ascorbic acid 2-glucoside and the like. Examples of L-ascorbic acid and derivatives thereof include L-ascorbic acid, L-ascorbic acid phosphate, L-ascorbic acid-2-sulfate, L-ascorbic acid 2-glucoside, or salts thereof.
Examples of the tranexamic acid derivative include a dimer of tranexamic acid (for example, trans-4- (trans-aminomethylcyclohexanecarbonyl) aminomethylcyclohexanecarboxylic acid, etc.), an ester of tranexamic acid and hydroquinone (for example, trans-4 -Aminomethylcyclohexanecarboxylic acid 4'-hydroxyphenyl ester, etc.), ester form of tranexamic acid and gentisic acid (for example, 2- (trans-4-aminomethylcyclohexylcarbonyloxy) -5-hydroxybenzoic acid and its salt, ), Amides of tranexamic acid (for example, trans-4-aminomethylcyclohexanecarboxylic acid methylamide and salts thereof, trans-4- (P-methoxybenzoyl) aminomethylcyclohexanecarboxylic acid and And salts of trans-4-guanidinomethylcyclohexanecarboxylic acid and salts thereof, and the like.
Examples of the anti-inflammatory agent include glycyrrhizin, glycyrrhizinate (eg, dipotassium glycyrrhizinate, ammonium glycyrrhizinate, etc.), allantoin and the like.
Examples of the antibacterial agent include resorcin, sulfur, salicylic acid and the like.
Examples of the hormone agent include oxytocin, corticotropin, vasopressin, secretin, gastrin, calcitonin, hinokitiol, ethinyl estradiol and the like.
Examples of vitamins include vitamin A and its derivatives (for example, retinol, vitamin A palmitate, etc.), vitamin B6, vitamin B6 derivatives such as vitamin B6 hydrochloride, nicotinic acid derivatives such as nicotinic acid and nicotinamide, vitamin E And derivatives thereof, β-carotene and the like.
Examples of various amino acids and their derivatives and enzymes include L-glutamic acid, urocanic acid, trypsin, lysozyme chloride, chymotrypsin, semi-alkaline proteinase, serrapeptase, lipase, and hyaluronidase.
Examples of the antioxidant include thiotaurine, glutathione, catechin, albumin, ferritin, metallothionein and the like.
Examples of the hair restoring agent include β-glycyrrhetinic acid, pantothenyl ethyl ether, minoxidil and the like.
Also, a refreshing agent such as camphor or menthol can be used.
次に実施例を挙げて本発明を説明する。本発明はこれら実施例に限定されるものではない。最初に、実施例に使用した共重合体(ミクロゲル)の製造例を示す。配合量は特に断りのない限り、質量%で表す。 Next, an Example is given and this invention is demonstrated. The present invention is not limited to these examples. Initially, the manufacture example of the copolymer (microgel) used for the Example is shown. Unless otherwise specified, the amount is expressed in mass%.
「ミクロゲルの製造例」
ミクロゲルの重合は以下の方法で実施した。還流管と窒素導入管を備えた200mLの三口フラスコに水−エタノール混合溶媒(水:エタノール=60:40容量比)50mLにPME−4000、メチルメタクリレート(MMA)、ブチルメタクリレート(nBMA)、2−エチルヘキシルメタクリレート(EHMA)およびエチレングリコールジメタクリレート(EGDMA)を溶解する。十分溶解した後、2,2'アゾビス(2メチルプロピオンアミジン 2塩酸塩)を全モノマー量に対して1mol%の割合で添加してさらに溶解する。完全に均一になった重合溶液を20分間窒素置換して溶存酸素を除いた後、マグネチックスターラーで攪拌しながら、オイルバスにて65から70℃に8時間保って重合する。重合終了後、重合液を室温に戻した後、重合液を水に対して5日間透析して、残存モノマーを除去し、同時に分散液を水に置換する。
用いたモノマーの量(g)を「表1」に示す。
"Examples of microgel production"
The polymerization of the microgel was carried out by the following method. In a 200 mL three-necked flask equipped with a reflux tube and a nitrogen introduction tube, 50 mL of a water-ethanol mixed solvent (water: ethanol = 60: 40 volume ratio) was added to PME-4000, methyl methacrylate (MMA), butyl methacrylate (nBMA), 2- Dissolve ethylhexyl methacrylate (EHMA) and ethylene glycol dimethacrylate (EGDMA). After sufficiently dissolving, 2,2 ′ azobis (2-methylpropionamidine dihydrochloride) is added at a ratio of 1 mol% with respect to the total monomer amount and further dissolved. The completely homogenized polymerization solution is purged with nitrogen for 20 minutes to remove dissolved oxygen, and then stirred for 8 hours in an oil bath at 65 to 70 ° C. while stirring with a magnetic stirrer. After completion of the polymerization, the polymerization solution is returned to room temperature, and then the polymerization solution is dialyzed against water for 5 days to remove residual monomers, and at the same time, the dispersion is replaced with water.
The amount (g) of the monomer used is shown in “Table 1”.
「粒子径及び分散度の測定方法」
ミクロゲルの粒子径の測定は、マルバーン社製 ゼータサイザーを用いて測定した。ミクロゲル分散液のミクロゲル濃度を約0.1%に調製し測定サンプルを作成し、0.45マイクロメーターのフィルターでごみを除去した後、25℃での散乱強度を散乱角度90°で測定し、測定装置に搭載されている解析ソフトで平均粒子径および分散度を算出した。粒子径はキュムラント解析法により解析し、分散度はキュムラント解析で得られる2次キュムラントの値を規格化した数値である。この分散度は一般的に用いられているパラメーターであり、市販の動的光散乱測定装置を用いることで自動的に解析が可能である。粒子径解析に必要な溶媒の粘度は25℃の純水の粘度、即ち0.89mPasの値を用いた。
測定は各サンプルについて10回の測定を行いその平均値をとった。
"Measurement method of particle size and degree of dispersion"
The particle size of the microgel was measured using a Zetasizer manufactured by Malvern. The microgel concentration of the microgel dispersion is adjusted to about 0.1%, a measurement sample is prepared, dust is removed with a 0.45 micrometer filter, the scattering intensity at 25 ° C. is measured at a scattering angle of 90 °, The average particle size and the degree of dispersion were calculated with analysis software installed in the measuring device. The particle diameter is analyzed by a cumulant analysis method, and the degree of dispersion is a numerical value obtained by standardizing the value of the secondary cumulant obtained by the cumulant analysis. This degree of dispersion is a commonly used parameter and can be automatically analyzed by using a commercially available dynamic light scattering measurement device. As the viscosity of the solvent necessary for the particle size analysis, the viscosity of pure water at 25 ° C., that is, a value of 0.89 mPas was used.
The measurement was performed 10 times for each sample, and the average value was taken.
「ミクロゲルの粒子径および分散度」
得られたミクロゲルの粒子径および分散度を「表2」に示す。
The particle diameter and dispersity of the obtained microgel are shown in “Table 2”.
次に皮膚外用剤にミクロゲルを配合した実施例について説明する。
なお、本発明の実施例説明に先立ち、評価方法を以下に示す。
「コンダクタンス測定による試験法」
10名のパネルの前腕部を用い、塗布前と塗布後120分後の皮膚コンダクタンスを測定し、この変化率から保湿効果を評価した。尚、皮膚コンダクタンス上昇率により、角層の吸水性、水分保持能への影響を検討することが可能であり、上昇率が大きいほど、角層水分の増加があり、保湿効果が高いと評価できる。
Next, the Example which mix | blended microgel with the skin external preparation is described.
Prior to the description of the examples of the present invention, an evaluation method is shown below.
"Test method by conductance measurement"
The skin conductance before and 120 minutes after application was measured using the forearm of 10 panelists, and the moisturizing effect was evaluated from the rate of change. In addition, it is possible to examine the effect of the stratum corneum on the water absorption and water retention capacity by the skin conductance increase rate, and it can be evaluated that the greater the increase rate, the more the stratum corneum moisture increases and the higher the moisturizing effect. .
「評価(1)コンダクタンス測定による試験」の評価基準は以下の通りである。
◎・・・パネル10名のコンダクタンス上昇率の平均が40%以上
○・・・パネル10名のコンダクタンス上昇率の平均が25%以上、40%未満
△・・・パネル10名のコンダクタンス上昇率の平均が10%以上、25%未満
×・・・パネル10名のコンダクタンス上昇率の平均が10%未満
The evaluation criteria of "Evaluation (1) Test by conductance measurement" are as follows.
◎ ・ ・ ・ The average conductance increase rate of 10 panelists is 40% or more ○ ・ ・ ・ The average conductance increase rate of 10 panelists is 25% or more and less than 40% Δ ・ ・ ・ The conductance increase rate of 10 panelists The average is 10% or more and less than 25% x ... The average conductance increase rate of 10 panelists is less than 10%
「評価(2):肌のなめらかさ」
使用中及び使用後の肌のなめらかさを専門パネラー10名により実使用試験を実施した。評価基準は以下の通りである。
◎・・・専門パネラー8名以上が使用中及び使用後肌がなめらかであると認めた。
○・・・専門パネラー6名以上8名未満が使用中及び使用後肌がなめらかであると認めた。
△・・・専門パネラー3名以上6名未満が使用中及び使用後肌がなめらかであると認めた。
×・・・専門パネラー3名未満が使用中及び使用後肌がなめらかであると認めた。
"Evaluation (2): Smooth skin"
An actual use test was conducted by 10 professional panelists on the smoothness of the skin during and after use. The evaluation criteria are as follows.
◎ ... More than 8 professional panelists recognized that the skin was smooth during and after use.
○ ... 6 or more and less than 8 professional panelists recognized that the skin was smooth during use and after use.
Δ: 3 or more and less than 6 professional panelists recognized that the skin was smooth during and after use.
X: Less than 3 professional panelists recognized that the skin was smooth during use and after use.
「評価(3):肌へのべたつきのなさ」
使用中及び使用後の肌へのべたつきのなさを専門パネラー10名により実使用試験を実施した。評価基準は以下の通りである。
◎・・・専門パネラー8名以上が使用中及び使用後肌へのべたつきがないと認めた。
○・・・専門パネラー6名以上8名未満が使用中及び使用後肌へのべたつきがないと認めた。
△・・・専門パネラー3名以上6名未満が使用中及び使用後肌へのべたつきがないと認めた。
×・・・専門パネラー3名未満が使用中及び使用後肌へのべたつきがないと認めた。
“Evaluation (3): No stickiness on the skin”
An actual use test was conducted by 10 professional panelists on the non-stickiness of the skin during and after use. The evaluation criteria are as follows.
◎ ... More than 8 professional panelists recognized that there was no stickiness on the skin during and after use.
○ ... 6 or more professional panelists recognized that there was no stickiness on the skin during and after use.
Δ: 3 or more professional panelists recognized that there was no stickiness on the skin during and after use.
X: Less than 3 professional panelists recognized that there was no stickiness to the skin during and after use.
「評価(4):保湿効果感」
使用120分後の保湿効果感の有無を専門パネラー10名により実使用試験を実施した。評価基準は以下の通りである。
◎・・・専門パネラー8名以上が、保湿効果感があると認めた。
○・・・専門パネラー6名以上8名未満が、保湿効果感があると認めた。
△・・・専門パネラー3名以上6名未満が、保湿効果感があると認めた。
×・・・専門パネラー3名未満が、保湿効果感があると認めた。
“Evaluation (4): Moisturizing effect”
An actual use test was conducted by 10 professional panelists for the presence or absence of a moisturizing effect after 120 minutes of use. The evaluation criteria are as follows.
◎ ・ ・ ・ 8 or more professional panelists recognized that there was a moisturizing effect.
○ ... 6 or more and less than 8 professional panelists recognized that there was a moisturizing effect.
Δ: 3 or more and less than 6 professional panelists recognized that there was a moisturizing effect.
X: Less than 3 professional panelists recognized that there was a moisturizing effect.
「評価(5):肌荒れ改善効果試験」
顔(部位:頬)に肌荒れをおこしている1 0 名のパネルにより、肌荒れ改善効果試験を実施した。試験法は左右の頬に、異なる化粧水を1 週間塗布し、その期間終了後の翌日に判定した。評価基準は以下の通りである。
◎・・・パネル8名以上が、肌荒れが改善されていると認めた。
○・・・パネル6名以上8名未満が、肌荒れが改善されていると認めた。
△・・・パネル3名以上6名未満が、肌荒れが改善されていると認めた。
×・・・パネル3名未満が、肌荒れが改善されていると認めた。
“Evaluation (5): Skin roughness improvement effect test”
A rough skin improvement effect test was conducted with 10 panels with rough skin on the face (part: cheek). In the test method, different lotions were applied to the left and right cheeks for one week, and the determination was made the next day after the period. The evaluation criteria are as follows.
◎ ... 8 or more panelists recognized that the rough skin was improved.
○ ... 6 or more and less than 8 panelists recognized that rough skin was improved.
Δ: 3 or more and less than 6 panelists recognized that rough skin was improved.
X: Less than 3 panelists recognized that rough skin was improved.
「ミクロゲルの組成の影響」
下記試験用基本組成を用いてその皮膚外用剤としての評価を行った。
イオン交換水 to 100 質量%
エチルアルコール 10
製造例1−7のミクロゲル(A) 0.1
グリセリン 8.0
クエン酸 適量
クエン酸ナトリウム 適量
ヘキサメタリン酸ソーダ 適量
フェノキシエタノール 適量
香料 適量
"Effects of microgel composition"
Evaluation as a skin external preparation was performed using the following basic composition for test.
Ion exchange water to 100% by mass
Ethyl alcohol 10
Microgel (A) of Production Example 1-7 0.1
Glycerin 8.0
Citric acid Appropriate amount Sodium citrate Appropriate amount Sodium hexametaphosphate Appropriate amount Phenoxyethanol Appropriate amount Fragrance Appropriate amount
(A)
上記表3に示されるように、さまざまな組成の共重合体を配合した皮膚外用剤は、コンダクタンス測定、なめらかさ、べたつき、保湿効果感、肌荒れ改善効果の全てに優れている。 As shown in Table 3, the external preparation for skin containing copolymers of various compositions is excellent in all of conductance measurement, smoothness, stickiness, moisturizing effect, and rough skin improvement effect.
「ミクロゲルの配合量の影響」
下記試験用基本組成を用いてその皮膚外用剤としての評価を行った。
イオン交換水 to 100 質量%
エチルアルコール 10
製造例4のミクロゲル (B)
グリセリン 8.0
クエン酸 適量
クエン酸ナトリウム 適量
ヘキサメタリン酸ソーダ 適量
フェノキシエタノール 適量
香料 適量
"Effects of microgel content"
Evaluation as a skin external preparation was performed using the following basic composition for test.
Ion exchange water to 100% by mass
Ethyl alcohol 10
Microgel of Production Example 4 (B)
Glycerin 8.0
Citric acid Appropriate amount Sodium citrate Appropriate amount Sodium hexametaphosphate Appropriate amount Phenoxyethanol Appropriate amount Fragrance Appropriate amount
(B)
上記表4に示されるように、皮膚外用剤への共重合体の配合量は、0.01〜20質量%が好ましく、0.1〜1.0質量%が特に好ましい。 As shown in Table 4 above, the blending amount of the copolymer in the external preparation for skin is preferably 0.01 to 20% by mass, particularly preferably 0.1 to 1.0% by mass.
「保湿剤の配合量の影響」
下記試験用基本組成を用いてその皮膚外用剤としての評価を行った。
イオン交換水 to 100 質量%
エチルアルコール 10
製造例4のミクロゲル 0.1
保湿剤 (C)
クエン酸(食品) 適量
クエン酸ナトリウム 適量
ヘキサメタリン酸ソーダ 適量
フェノキシエタノール 適量
香料 適量
"Effects of humectant content"
Evaluation as a skin external preparation was performed using the following basic composition for test.
Ion exchange water to 100% by mass
Ethyl alcohol 10
Microgel of Production Example 4 0.1
Moisturizer (C)
Citric acid (food) Appropriate amount Sodium citrate Appropriate amount Sodium hexametaphosphate Appropriate amount Phenoxyethanol Appropriate amount Fragrance Appropriate amount
(C)
上記表5に示されるように、保湿剤の配合量は0.1〜30質量%が好ましく、1〜15質量%が特に好ましい。 As shown in Table 5 above, the content of the humectant is preferably 0.1 to 30% by mass, and particularly preferably 1 to 15% by mass.
下記に本発明のその他の皮膚外用剤を挙げる。
本発明は、化粧品原料油分をはじめ、さらに油溶性薬剤及び/又は香料を含有する化粧料においても、優れた皮膚外用剤を提供することが可能である。
The following are other skin external preparations of the present invention.
INDUSTRIAL APPLICABILITY The present invention can provide an excellent skin external preparation even in cosmetics containing a cosmetic raw material oil and further containing an oil-soluble drug and / or a fragrance.
「実施例22 乳液」
製造例1のミクロゲル 1.0
ジメチルポリシロキサン 3.0
デカメチルシクロペンタシロキサン 4.0
エチルアルコール 5.0
グリセリン 6.0
1,3−ブチレングリコール 5.0
ポリオキシエチレンメチルグルコシド 3.0
POE(14)POP(7)ジメチルエーテル 1.0
アスコルビン酸グルコシド 2.0
ヒマワリ油 1.0
スクワラン 2.0
水酸化カリウム 0.1
ヘキサメタリン酸ナトリウム 0.05
ヒドロキシプロピル−β−シクロデキストリン 0.1
グリチルリチン酸ジカリウム 0.05
ビワ葉エキス 0.1
L−グルタミン酸ナトリウム 0.05
ウイキョウエキス 0.1
酵母エキス 0.1
ラベンダー油 0.1
ジオウエキス 0.1
ジモルホリノピリダジノン 0.1
キサンタンガム 0.1
カルボキシビニルポリマー 0.1
アクリル酸・メタクリル酸アルキル共重合体(ペミュレンTR−1)
0.1
ベンガラ 適量
黄酸化鉄 適量
パラベン 適量
精製水 残余
"Example 22 Latex"
Microgel of Production Example 1 1.0
Dimethylpolysiloxane 3.0
Decamethylcyclopentasiloxane 4.0
Ethyl alcohol 5.0
Glycerin 6.0
1,3-butylene glycol 5.0
Polyoxyethylene methyl glucoside 3.0
POE (14) POP (7) Dimethyl ether 1.0
Ascorbic acid glucoside 2.0
Sunflower oil 1.0
Squalane 2.0
Potassium hydroxide 0.1
Sodium hexametaphosphate 0.05
Hydroxypropyl-β-cyclodextrin 0.1
Dipotassium glycyrrhizinate 0.05
Loquat leaf extract 0.1
Sodium L-glutamate 0.05
Fennel extract 0.1
Yeast extract 0.1
Lavender oil 0.1
Giant extract 0.1
Dimorpholinopyridazinone 0.1
Xanthan gum 0.1
Carboxyvinyl polymer 0.1
Acrylic acid / alkyl methacrylate copolymer (Pemulene TR-1)
0.1
Bengala Appropriate amount Yellow iron oxide Appropriate amount Paraben Appropriate amount Purified water Residual
「実施例23 保湿クリーム」
製造例5のミクロゲル 2.0
α−オレフィンオリゴマー 10
ワセリン 1.0
マイクロクリスタリンワックス 3.0
デカメチルシクロペンタシロキサン 5.0
グリセリン 10
ジプロピレングリコール 2.0
1,3−ブチレングリコール 2.0
エリスリトール 2.0
スクワラン 1.0
POE(17)POP(4)ジメチルエーテル 2.0
グリセリン脂肪酸エステルエイコサンニ酸縮合物 0.1
イソステアリン酸 1.0
2−エチルヘキサン酸セチル 5.0
塩化ナトリウム 0.5
ヘキサメタリン酸ナトリウム 0.05
グリチルレチン酸ステアリル 0.05
コウボエキス 0.1
リン酸L−アスコルビルマグネシウム 2.0
酢酸トコフェロール 0.5
チオタウリン 0.1
DL−ピロリドンカルボン酸ナトリウム 1.0
ウコンエキス 0.1
エデト酸3ナトリウム 0.1
ジメチルジステアリルアンモニウムヘクトライト 2.0
カルボキシメチルセルロースナトリウム 0.1
パラベン 適量
精製水 残余
香料 適量
"Example 23 moisturizing cream"
Microgel of Production Example 5 2.0
α-Olefin oligomer 10
Vaseline 1.0
Microcrystalline wax 3.0
Decamethylcyclopentasiloxane 5.0
Glycerin 10
Dipropylene glycol 2.0
1,3-butylene glycol 2.0
Erythritol 2.0
Squalane 1.0
POE (17) POP (4) Dimethyl ether 2.0
Glycerin fatty acid ester eicosannic acid condensate 0.1
Isostearic acid 1.0
Cetyl 2-ethylhexanoate 5.0
Sodium chloride 0.5
Sodium hexametaphosphate 0.05
Stearyl glycyrrhetinate 0.05
Koubo extract 0.1
L-ascorbyl magnesium phosphate 2.0
Tocopherol acetate 0.5
Thiotaurine 0.1
DL-pyrrolidonecarboxylate sodium 1.0
Turmeric extract 0.1
Edetate trisodium 0.1
Dimethyl distearyl ammonium hectorite 2.0
Sodium carboxymethylcellulose 0.1
Paraben Suitable amount Purified water Residual flavor
「実施例24 目元用クリーム」
製造例5のミクロゲル 1.0
デカメチルシクロペンタシロキサン 15
トリメチルシロキシケイサン−オクタメチルシクロテトラシロキサン
7.5
ポリオキシエチレン・メチルポリシロキサン共重合体 2.0
グリセリン 15
1,3−ブチレングリコール 3.0
マルチトール液 2.0
マカデミアナッツ油 0.5
スクワラン 1.0
ヒドロキシステアリン酸コレステリル 0.1
2−エチルヘキサン酸セチル 2.0
塩化ジステアリルジメチルアンモニウム 0.2
L-アスコルビン酸硫酸エステル2ナトリウム 0.01
DL−α−トコフェロール2−L−アスコルビン酸リン酸ジエステル
0.02
酢酸DL−α−トコフェロール 0.05
サクシニルアテロコラーゲン液 0.4
ヒアルロン酸ナトリウム 0.002
p−オキシ安息香酸エステル 0.15
エデト酸3Na 0.02
ジパラメトキシケイヒ酸モノ−2−エチルヘキサン酸グリセリル 0.02
ケイ酸アルミニウムマグネシウム 0.3
精製水 残余
"Example 24 Eye cream"
Microgel of Production Example 5 1.0
Decamethylcyclopentasiloxane 15
Trimethylsiloxysilicate-octamethylcyclotetrasiloxane
7.5
Polyoxyethylene / methylpolysiloxane copolymer 2.0
Glycerin 15
1,3-butylene glycol 3.0
Maltitol solution 2.0
Macadamia nut oil 0.5
Squalane 1.0
Cholesteryl hydroxystearate 0.1
Cetyl 2-ethylhexanoate 2.0
Distearyldimethylammonium chloride 0.2
L-ascorbic acid sulfate disodium 0.01
DL-α-tocopherol 2-L-ascorbic acid diester
0.02
DL-α-tocopherol acetate 0.05
Succinyl atelocollagen solution 0.4
Sodium hyaluronate 0.002
p-Oxybenzoate ester 0.15
Edetic acid 3Na 0.02
Diparamethoxycinnamic acid mono-2-ethylhexanoate glyceryl 0.02
Aluminum magnesium silicate 0.3
Purified water residue
「実施例25 日中美容液」
製造例2のミクロゲル 0.5
ジメチルポリシロキサン 5.0
デカメチルシクロペンタシロキサン 25
トリメチルシロキシケイ酸 5.0
ポリオキシエチレン・メチルポリシロキサン共重合体 2.0
ジプロピレングリコール 5.0
微粒子酸化亜鉛 15
パラベン 適量
フェノキシエタノール 適量
エデト酸三ナトリウム 適量
アルブチン 3.0
パラメトキシ桂皮酸2−エチルヘキシル 7.5
ジメチルジステアリルアンモニウムヘクトライト 0.5
球状ポリアクリル酸アルキル粉末 5.0
精製水 残余
香料 適量
“Example 25 Daytime serum”
Microgel of Production Example 2 0.5
Dimethylpolysiloxane 5.0
Decamethylcyclopentasiloxane 25
Trimethylsiloxysilicate 5.0
Polyoxyethylene / methylpolysiloxane copolymer 2.0
Dipropylene glycol 5.0
Fine zinc oxide 15
Paraben Appropriate amount Phenoxyethanol Appropriate amount Trisodium edetate Appropriate amount Arbutin 3.0
2-Ethylhexyl paramethoxycinnamate 7.5
Dimethyl distearyl ammonium hectorite 0.5
Spherical polyalkyl acrylate powder 5.0
Purified water Residual fragrance Appropriate amount
「実施例26 含浸マスク」
製造例1のミクロゲル 0.1
グリセリン 1.0
1,3−ブチレングリコール 8.0
キシリット 2.0
ポリエチレングリコール1500 2.0
ローズマリー油 0.01
セージ油 0.1
クエン酸 0.02
クエン酸ナトリウム 0.08
ヘキサメタリン酸ナトリウム 0.01
ヒドロキシプロピル−β−シクロデキストリン 0.1
トラネキサム酸 2.0
ビタミンEアセテート 1.0
アロエ抽出液 0.1
バーチエキス 0.1
ラベンダー油 0.01
キサンタンガム 0.05
カルボキシビニルポリマー 0.15
パラオキシ安息香酸エステル 適量
精製水 残余
"Example 26 impregnation mask"
Microgel of Production Example 1 0.1
Glycerin 1.0
1,3-butylene glycol 8.0
Xylit 2.0
Polyethylene glycol 1500 2.0
Rosemary oil 0.01
Sage oil 0.1
Citric acid 0.02
Sodium citrate 0.08
Sodium hexametaphosphate 0.01
Hydroxypropyl-β-cyclodextrin 0.1
Tranexamic acid 2.0
Vitamin E acetate 1.0
Aloe extract 0.1
Birch extract 0.1
Lavender oil 0.01
Xanthan gum 0.05
Carboxyvinyl polymer 0.15
P-Hydroxybenzoate appropriate amount purified water remaining
「実施例27 とろみ化粧水」
製造例4のミクロゲル 0.8
グリセリン 1.0
ジプロピレングリコール 12
エタノール 8.0
POEメチルグルコシド 3.0
POE(24)POP(13)デシルテトラデシルエーテル 0.5
クエン酸 0.02
クエン酸ナトリウム 0.08
ヒドロキシプロピル−β−シクロデキストリン 0.5
チオタウリン 0.1
アデノシン3リン酸−2ナトリウム 0.1
コンドロイチン硫酸ナトリウム 0.01
EDTA3ナトリウム 0.01
ヒドロキシエチルセルロース 0.1
水酸化カリウム 0.2
パラベン 適量
精製水 残余
香料 適量
"Example 27 Thorough lotion"
Microgel of Production Example 4 0.8
Glycerin 1.0
Dipropylene glycol 12
Ethanol 8.0
POE methyl glucoside 3.0
POE (24) POP (13) Decyl tetradecyl ether 0.5
Citric acid 0.02
Sodium citrate 0.08
Hydroxypropyl-β-cyclodextrin 0.5
Thiotaurine 0.1
Adenosine triphosphate-2sodium 0.1
Sodium chondroitin sulfate 0.01
EDTA 3 sodium 0.01
Hydroxyethyl cellulose 0.1
Potassium hydroxide 0.2
Paraben Suitable amount Purified water Residual flavor
「実施例28 コンディショナー」
製造例7のミクロゲル 5.0
ジメチルポリシロキサン 2.0
ステアリルアルコール 2.0
ベヘニルアルコール 1.0
グリセリン 1.5
パルミチン酸オクチル 1.0
ポリオキシエチレンステアリルエーテル 0.2
クエン酸 0.05
パラオキシ安息香酸エステル 適量
フェノキシエタノール 適量
ヒドロキシエチルセルロース 0.1
塩化ステアリルトリメチルアンモニウム 1
高重合メチルポリシロキサン 1.5
精製水 残余
香料 適量
"Example 28 Conditioner"
Microgel of Production Example 7 5.0
Dimethylpolysiloxane 2.0
Stearyl alcohol 2.0
Behenyl alcohol 1.0
Glycerin 1.5
Octyl palmitate 1.0
Polyoxyethylene stearyl ether 0.2
Citric acid 0.05
Paraoxybenzoic acid ester Appropriate amount Phenoxyethanol Appropriate amount Hydroxyethylcellulose 0.1
Stearyltrimethylammonium chloride 1
Highly polymerized methylpolysiloxane 1.5
Purified water Residual fragrance Appropriate amount
「実施例28 クリームファンデーション」
製造例3のミクロゲル 0.1
ベヘニルアルコール 0.5
ジプロピレングリコール 6.0
ステアリン酸 1.0
モノステアリン酸グリセリン 1.0
水酸化カリウム 0.2
トリエタノールアミン 0.8
酢酸DL−α−トコフェロール 0.1
パラオキシ安息香酸エステル 適量
黄酸化鉄 1.0
α−オレフィンオリゴマー 3.0
ジメチルポリシロキサン(6mPa.s) 2.0
ジメチルポリシロキサン(100mPa.s) 5.0
バチルアルコール 0.5
イソステアリン酸 1.0
ベヘニン酸 0.5
2−エチルヘキサン酸セチル 10
モノステアリン酸ポリオキシエチレングリセリン 1.0
酸化チタン 3.0
雲母チタン・ポリアクリル酸アルキル複合粉末 0.5
表面処理酸化チタン(MT−062) 10
ポリアクリ酸アルキル被覆雲母チタン 0.5
黒酸化鉄被覆雲母チタン 0.5
無水ケイ酸 6.0
パラメトキシケイ皮酸2−エチルへキシル 2.0
ベンガラ 適量
群青 適量
黒酸化鉄 適量
法定色素 適量
キサンタンガム 0.1
ベントナイト 1
カルボキシメチルセルロースナトリウム 0.1
精製水 残余
香料 適量
"Example 28 cream foundation"
Microgel of Production Example 3 0.1
Behenyl alcohol 0.5
Dipropylene glycol 6.0
Stearic acid 1.0
Glycerol monostearate1.0
Potassium hydroxide 0.2
Triethanolamine 0.8
DL-α-tocopherol acetate 0.1
P-Hydroxybenzoate appropriate amount yellow iron oxide 1.0
α-Olefin oligomer 3.0
Dimethylpolysiloxane (6 mPa.s) 2.0
Dimethylpolysiloxane (100 mPa.s) 5.0
Batyl alcohol 0.5
Isostearic acid 1.0
Behenic acid 0.5
Cetyl 2-ethylhexanoate 10
Polyoxyethylene glycerol monostearate1.0
Titanium oxide 3.0
Mica titanium / polyalkyl acrylate composite powder 0.5
Surface-treated titanium oxide (MT-062) 10
Polyacrylic acid-coated mica titanium 0.5
Black iron oxide coated mica titanium 0.5
Silica anhydride 6.0
2-Ethylhexyl paramethoxycinnamate 2.0
Bengala Appropriate amount of blue, appropriate amount of black iron oxide
Bentonite 1
Sodium carboxymethylcellulose 0.1
Purified water Residual fragrance Appropriate amount
「実施例29 ボディーシャンプー」
製造例4のミクロゲル 0.5
エタノール 10
グリセリン 1.0
オレンジ油 0.05
ローズマリー油 0.05
ポリオキシエチレンステアリルエーテル 0.5
ヤシ油脂肪酸アシル−グルタミン酸カリウム混合液 10
ヤシ油脂肪酸メチルタウリンナトリウム 5.0
2−アルキル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタイン
1.5
ヒアルロン酸ナトリウム 0.05
クエン酸 0.1
クエン酸ナトリウム 0.2
グリチルリチン酸ジカリウム 0.1
エチレンジアミンヒドロキシエチル三酢酸三ナトリウム 適量
キサンタンガム 0.5
精製水 残余
"Example 29 body shampoo"
Microgel of Production Example 4 0.5
Ethanol 10
Glycerin 1.0
Orange oil 0.05
Rosemary oil 0.05
Polyoxyethylene stearyl ether 0.5
Coconut oil fatty acid acyl-potassium glutamate mixed solution 10
Palm oil fatty acid methyl taurine sodium 5.0
2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine
1.5
Sodium hyaluronate 0.05
Citric acid 0.1
Sodium citrate 0.2
Dipotassium glycyrrhizinate 0.1
Ethylenediamine hydroxyethyl triacetate trisodium xanthan gum 0.5
Purified water residue
本発明によれば、保湿効果と肌荒れ改善効果があり、かつ使用感に優れた皮膚外用剤を提供することが出来る。
本発明の皮膚外用剤が化粧料の場合には、その優れた使用感から、化粧料効果の印象を使用者に極めて有効にアピールできる有用な化粧料である。
ADVANTAGE OF THE INVENTION According to this invention, it can provide the skin external preparation which has a moisturizing effect and a rough skin improvement effect, and was excellent in the usability | use_condition.
When the external preparation for skin of the present invention is a cosmetic, it is a useful cosmetic that can appeal the impression of the cosmetic effect to the user very effectively from its excellent feeling of use.
Claims (3)
R1は炭素原子数1〜3のアルキルを表し、nは20〜200の数である。XはHまたはCH3を表す。
R2は炭素原子数1〜3のアルキルを表し、R3は炭素原子数1〜8のアルキルを表す。
R4とR5はそれぞれ独立に炭素原子数1〜3のアルキルを表し、mは0〜2の数である。 It contains a copolymer obtained by polymerizing a polyethylene oxide macromonomer of the following formula (1), a hydrophobic monomer of the following formula (2) and a crosslinkable monomer of the following formula (3), and a humectant. A topical skin preparation.
R 1 represents alkyl having 1 to 3 carbon atoms, and n is a number from 20 to 200. X represents H or CH 3 .
R 2 represents alkyl having 1 to 3 carbon atoms, and R 3 represents alkyl having 1 to 8 carbon atoms.
R 4 and R 5 each independently represents alkyl having 1 to 3 carbon atoms, and m is a number from 0 to 2.
(A)疎水性モノマーは炭素原子数1〜8のアルキルを有するメタクリル酸誘導体を一種もしくは二種以上を混合した組成であること
(B)ポリエチレンオキサイドマクロモノマーと疎水性モノマーの仕込み量が、ポリエチレンオキサイドマクロモノマー:疎水性モノマー=1:10〜1:250(モル比)であること
(C)架橋性モノマーの仕込み量が、疎水性モノマーの仕込み量に対して、0.1〜1.5質量%であること
(D)水−エタノール混合溶媒が、水:エタノール=90〜30:10〜70(20℃の容積比)であること From a copolymer obtained by radical polymerization of the monomers (1) to (3) in a water-ethanol mixed solvent under the following conditions (A), (B), (C) and (D): The skin external preparation characterized by mix | blending this microgel and a moisturizer.
(A) The hydrophobic monomer has a composition in which one or more methacrylic acid derivatives having an alkyl having 1 to 8 carbon atoms are mixed. (B) The charged amount of the polyethylene oxide macromonomer and the hydrophobic monomer is polyethylene. Oxide macromonomer: hydrophobic monomer = 1: 10 to 1: 250 (molar ratio) (C) The charged amount of the crosslinkable monomer is 0.1 to 1.5 with respect to the charged amount of the hydrophobic monomer. (D) The water-ethanol mixed solvent is water: ethanol = 90-30: 10-70 (20 ° C. volume ratio).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005298834A JP2007106694A (en) | 2005-10-13 | 2005-10-13 | Skin care agent for external use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005298834A JP2007106694A (en) | 2005-10-13 | 2005-10-13 | Skin care agent for external use |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2007106694A true JP2007106694A (en) | 2007-04-26 |
Family
ID=38032843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005298834A Withdrawn JP2007106694A (en) | 2005-10-13 | 2005-10-13 | Skin care agent for external use |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2007106694A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010044261A1 (en) * | 2008-10-15 | 2010-04-22 | 株式会社 資生堂 | Skin preparation composition for external use |
WO2013094298A1 (en) * | 2011-12-22 | 2013-06-27 | 株式会社資生堂 | Core-corona type microgel emulsifier, and oil-in-water emulsion composition |
WO2020075666A1 (en) * | 2018-10-09 | 2020-04-16 | 株式会社 資生堂 | Water-in-oil type emulsion composition |
JP2020519708A (en) * | 2017-05-01 | 2020-07-02 | ゴジョ・インダストリーズ・インコーポレイテッド | Alcohol containing non-antibacterial cleaning composition |
-
2005
- 2005-10-13 JP JP2005298834A patent/JP2007106694A/en not_active Withdrawn
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010044261A1 (en) * | 2008-10-15 | 2010-04-22 | 株式会社 資生堂 | Skin preparation composition for external use |
JP2010116392A (en) * | 2008-10-15 | 2010-05-27 | Shiseido Co Ltd | Skin preparation composition for external use |
KR101969984B1 (en) | 2011-12-22 | 2019-04-17 | 가부시키가이샤 시세이도 | Core-corona type microgel emulsifier, and oil-in-water emulsion composition |
KR20140113900A (en) * | 2011-12-22 | 2014-09-25 | 가부시키가이샤 시세이도 | Core-corona type microgel emulsifier, and oil-in-water emulsion composition |
US9539554B2 (en) | 2011-12-22 | 2017-01-10 | Shiseido Company, Ltd. | Method of making oil-in-water emulsified composition using corona-core microgel emulsifying agent |
RU2607088C1 (en) * | 2011-12-22 | 2017-01-10 | Шисейдо Компани, Лтд. | "core-shell" type microgel emulsifier and "oil-in-water" emulsion composition |
US9539553B2 (en) | 2011-12-22 | 2017-01-10 | Shiseido Company, Ltd. | Corona-core microgel emulsifying agent and oil-in-water emulsified composition |
WO2013094298A1 (en) * | 2011-12-22 | 2013-06-27 | 株式会社資生堂 | Core-corona type microgel emulsifier, and oil-in-water emulsion composition |
JP2013147486A (en) * | 2011-12-22 | 2013-08-01 | Shiseido Co Ltd | Core-corona type microgel emulsifier and oil-in-water emulsion composition |
JP7071999B2 (en) | 2017-05-01 | 2022-05-19 | ゴジョ・インダストリーズ・インコーポレイテッド | Alcohol containing non-antibacterial cleaning composition |
JP2020519708A (en) * | 2017-05-01 | 2020-07-02 | ゴジョ・インダストリーズ・インコーポレイテッド | Alcohol containing non-antibacterial cleaning composition |
WO2020075666A1 (en) * | 2018-10-09 | 2020-04-16 | 株式会社 資生堂 | Water-in-oil type emulsion composition |
JPWO2020075666A1 (en) * | 2018-10-09 | 2021-10-07 | 株式会社 資生堂 | Water-in-oil emulsified composition |
CN112804986A (en) * | 2018-10-09 | 2021-05-14 | 株式会社资生堂 | Water-in-oil type emulsified composition |
CN112804986B (en) * | 2018-10-09 | 2023-05-02 | 株式会社资生堂 | Water-in-oil emulsion composition |
JP7356998B2 (en) | 2018-10-09 | 2023-10-05 | 株式会社 資生堂 | Water-in-oil emulsion composition |
US11931448B2 (en) | 2018-10-09 | 2024-03-19 | Shiseido Company, Ltd. | Water-in-oil type emulsion composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102223040B1 (en) | O/w type sunblock cosmetic | |
JP6321105B2 (en) | Oil-in-water emulsified cosmetic | |
KR101969984B1 (en) | Core-corona type microgel emulsifier, and oil-in-water emulsion composition | |
TW201944980A (en) | Cosmetic | |
WO2009145344A1 (en) | Oil‑in‑water type topical agent for skin | |
JP2008231010A (en) | External preparation for skin | |
JP2010120857A (en) | Skin external preparation | |
WO2014010622A1 (en) | Water-in-oil emulsion cosmetic | |
JP5117591B2 (en) | Water-in-oil emulsified cosmetic | |
JP2014101344A (en) | Cosmetic | |
WO2012017733A1 (en) | Skin cosmetic | |
JPH11335228A (en) | External preparation for skin | |
JP2010143830A (en) | Cosmetic containing polyvinyl alcohol fine particle | |
JP4577721B2 (en) | Cosmetics | |
CN106999385A (en) | Oil-in-water type ultraviolet protection cosmetics | |
JPH09315937A (en) | Gelled composition, emulsion composition and preparation for external use for skin | |
JP2007106694A (en) | Skin care agent for external use | |
JP2020007379A (en) | Water-in-oil emulsified cosmetic | |
JPH11263721A (en) | Oil-in-water type gommage (peeling) cosmetic | |
JP5770490B2 (en) | Oil-in-water emulsified cosmetic | |
JP2005132828A (en) | Composition for external application | |
JP3441387B2 (en) | Moisturizer, skin cosmetics and bath additives | |
JP2007126394A (en) | Multilayered cosmetic | |
JP2003286125A (en) | Water-in-oil type emulsified cosmetic | |
JP3634139B2 (en) | Oil-in-water emulsion composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20090106 |